New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Carvykti ciltacabtagene autoleucel |
Janssen | A new B-cell maturation antigen (BCMA)-directed T-cell IV immunotherapy for adults with multiple myeloma. |
|
Kengrexal cangrelor |
Methapharm | A new IV direct P2Y12 platelet receptor inhibitor for patients with coronary artery disease undergoing percutaneous coronary intervention (PCI). |
|
Vegzelma bevacizumab |
Celltrion | A biosimilar to Avastin. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Calquence acalabrutinib maleate |
AstraZeneca | New tablet dosage form that does not interact with gastric acid reducing agents |
| Brand/Generic | Company | Description |
|---|